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Cytosolic aspartate aminotransferase (cAspAT) is regulated by
glucocorticoids in rat liver and kidney. Part of this regulation is
mediated by an unusual glucocorticoid-responsive element
(GRE)-like sequence called GRE A. GRE A is composed of two
overlapping imperfect GREs, each comprising a conserved half-
site (half-sites 1 and 4 respectively) and a poorly conserved
half-site (half-sites 2 and 3 respectively). The sequence binds co-
operatively two dimers of the glucocorticoid receptor (GR) and
mediates efficient glucocorticoid regulation of gene expression.
Analysis of deletions of the cAspAT gene promoter and sub-
cloning of GRE A upstream of the thymidine kinase promoter
indicate that this sequence is responsive to glucocorticoids, but
not to androgens. Electrophoretic mobility shift assays indicate
that the GRE A unit does not bind the androgen receptor (AR).
The modification of three nucleotides in the poorly conserved
INTRODUCTION
The glucocorticoid receptor (GR) and the androgen receptor
(AR) are members of the steroid}nuclear receptor superfamily
[1], which also comprises the progesterone receptor (PR), the
mineralocorticoid receptor (MR), the oestrogen receptor (ER),
the thyroid receptor and the retinoid receptors. These nuclear
receptors are transcription factors that mediate the effects of a
variety of hormones. Upon ligand binding, the receptor can
activate transcription by interacting with specific DNA sequences
located within or in the vicinity of gene promoters.
All members of the first subfamily, which includes the AR, PR,
GR and MR, have sequence similarity in their DNA-binding
domains [2]. This group of receptors bind tightly to the same
consensus partially palindromic sequence, called the gluco-
corticoid-responsive element (GRE). The GRE is an inverted
repeat in which the half-sites are separated by 3 bp: 5« GGTACA
NNN TGTTCT 3« [3]. In in itro transcription assays, this
responsive element is not receptor-specific, which contrasts with
the observation that different steroids have different specific
effects in different cell types [4]. It therefore remains unclear how
a single element can mediate distinct physiological activities of
different hormones. Potential mechanisms that could account for
these specificities include cell-specific regulation of receptors
levels, tissue-specific ligand metabolism, such as the metabolism
of cortisol by 11β-hydroxysteroid dehydrogenase [5], receptor-
Abbreviations used: AR, androgen receptor ; cAspAT, cytosolic aspartate aminotransferase ; CAT, chloramphenicol acetyltransferase ; EMSA,
electrophoretic mobility shift assay ; ER, oestrogen receptor ; GR, glucocorticoid receptor ; GRE, glucocorticoid-responsive element ; cGRE, consensus
GRE; ov-cGRE, unit consisting of two overlapping consensus GREs; MR, mineralocorticoid receptor ; PR, progesterone receptor ; TK, thymidine kinase.
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half-sites 2 and 3, converting GRE A into two overlapping high-
affinity GREs (ov-cGRE), resulted in co-operative binding of the
AR. Furthermore, ov-cGRE efficiently mediated androgen regu-
lation of the thymidine kinase promoter. A single base modi-
fication in half-site 2 or 3 in GRE A allowed the binding of the
AR as one or two dimers respectively, and restored trans-
criptional activation by androgens only in the latter case. Thus
the poor affinity of the AR for half-sites 2 and 3 prevented its
binding to GRE A, indicating that the overlapping GRE A
sequence of the cAspAT gene promoter discriminates a
glucocorticoid-mediated from an androgen-mediated response.
Key words: androgen receptor, glucocorticoid receptor, over-
lapping GREs, tetramer, transcription.
specific interactions with transcription factors [6] and}or specific
interactions with variant GRE sequences. However, in the case
of many genes that are specifically regulated by a single or a few
steroid hormones, this question remains unanswered.
Cytosolic aspartate aminotransferase (cAspAT) is regulated
by glucocorticoids in rat liver and kidney [7,8]. We have identified
in the promoter of the cAspAT gene an unusual GRE-like
sequence (GRE A) composed of two overlapping GREs, each
comprising both a highly conserved and a poorly conserved half-
site [9] (see Figure 1). This sequence binds co-operatively a
tetramer of the GR, which mediates the glucocorticoid regulation
of this gene. Modification of the poorly conserved half-sites to
increase their affinity for GR gave a DNA sequence that also
bound a GR tetramer in a co-operative manner. This unit,
consisting of two overlapping consensus GREs (ov-cGRE,
formerly called GRE Aup [9]), mediated glucocorticoid induction
with a 4-fold higher efficiency than did the consensus GRE
(cGRE). Other members of the steroid hormone receptor family,
such as the ER, can also form tetramers on an overlapping
response element. The interaction of the ER with two over-
lapping oestrogen-responsive elements was less co-operative than
that of the GR with ov-cGRE [10]. This probably results from
the ER bending DNA to a greater extent than does the GR [11].
It was shown previously that, in the rat hepatoma cell line Fao,
in which the glucocorticoid induction of cAspAT was studied,
testosterone was inefficient [7]. However, the AR status of those
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Figure 1 DNA sequences of the various GREs used in the study
Thick arrows indicate conserved half-sites. Thin arrows indicate poorly conserved half-sites.
Modified nucleotides are indicated with a star.
cells was not established. In other studies that have been
conducted in epithelial rat prostate cells, which are known to
respond to androgens, it was shown that cAspAT was not
regulated by these hormones, despite the presence of a functional
AR [12,13]. Those studies suggested that the hormonal specificity
of cAspAT gene regulation could relate to an intrinsic property of
the cAspAT gene promoter. The aim of the present study was
to determine whether the structure of GRE A accounts for the
glucocorticoid-specific regulation of the cAspAT gene. We show
that GRE A does not bind the AR. Furthermore, this sequence
is not responsive to testosterone in its promoter context or in the
context of the heterologous thymidine kinase (TK) promoter
because of the low-affinity half-sites in it. Thus GRE A dis-
criminates glucocorticoid from androgen induction, and provides




The human hepatoma cell line HepG2 [14] and the monkey
kidney cell line Cos7 were maintained in Dulbecco’s minimal
essential medium supplemented with 10% (v}v) fetal calf serum
(Gibco), 100 units}ml penicillin, 100 µg}ml streptomycin
(Diamant) and 0.5 µg}ml fungizone (Squibb).
Plasmids
The expression vectors for the human GR and the human AR
were gifts from Dr R. Evans (The Sal Institute, La Jolla, CA,
U.S.A.) and Dr H. Klocker (University of Innsbruck, Austria)
respectively. Deletion constructs of cAspAT were described
previously by Aggerbeck et al. [8]. GRE oligonucleotides were
subcloned into the HindIII site of the TK-CAT plasmid (a gift
from Dr C. Forest, CNRS, Meudon, France). The double-
stranded oligomers (cGRE, ov-cGRE, GRE A, GRE A2 and
GRE A3) (Figure 1) have 5« extensions that are compatible with
a HindIII site. However, the restriction site is lost in the
recombinant plasmid. The luciferase plasmid, RSV-Luc, was
purchased from Promega.
Transfection experiments
Transfection experiments were performed as described by
Massaad et al. [15]. At 1 day before transfection, HepG2 cells (10'
cells}10 cm dish) were seeded in Dulbecco’s minimal essential
medium containing 10% (v}v) fetal calf serum. A portion of
10 ml of fresh medium containing 10% (v}v) charcoal-treated
serum was added to the cells 2–3 h before transfection. The
chloramphenicol acetyltransferase (CAT) plasmids (5 µg), the
human AR or human GR expression vectors (as indicated), and
the luciferase expression vector (1 µg) were introduced into the
cells by the calcium phosphate co-precipitation technique. Fol-
lowing a glycerol shock, 10 ml of fresh medium containing 5%
(v}v) charcoal-treated serum was added to the cells. After 16 h,
serum-free medium was added and cells were treated with the
various hormones or drugs tested. After an additional 24 h
incubation, cells were homogenized for CAT and luciferase
assays.
Luciferase assay
Luciferase activity was used to normalize transfection efficiency
[16] and was assayed according to the manufacturer’s instructions
(Promega). Briefly, transfected cells were washed twice with 5 ml
of calcium- and magnesium-free PBS, and lysed in 500 µl of
Reporter Lysis Buffer 1¬ (Promega) for 15 min. After centri-
fugation at 10000 g for 5 min, 20 µl of the supernatant was
mixed with 100 µl of luciferase assay reagent at room tem-
perature. Luciferase activity was measured using a luminometer
30 s after addition of the assay reagent.
CAT assay
CAT activity was determined using the two-phase assay de-
veloped by Neumann et al. [17]. Briefly, 60 µl of cellular extract,
heated at 65 °C for 10 min, was incubated with 1 mM chloram-
phenicol, 0.5 mM acetyl-CoA and 0.5 µCi of [$H]acetyl-CoA
(NEN product no. NET-290 L) at 37 °C for 30 min. The solution
was transferred to a mini-vial and layered with 4 ml of Econofluor
(NEN product no. NEF 969). After vigorous mixing, the two
phases were allowed to separate for at least 15 min, and the
radioactivity was determined by scintillation counting. Under
these conditions, the product of the reaction, acetylated chloram-
phenicol, but not unreacted acetyl-CoA, diffuses into the
Econofluor phase. For these experiments, blanks were obtained
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by assaying CAT activity in cells that had undergone the same
treatment in the absence of a CAT plasmid. Blank values for
luciferase and CAT assays were obtained by assaying lysates
from non-transfected cells. Transcriptional activation was
obtained by determining the ratio of CAT activity over luciferase
activity.
Preparation of cell extracts
Cos7 cells were transfected as described by Ishikawa et al. [18].
Briefly, cells were plated at 2¬10' cells}10 cm dish. After 24 h
the cells were washed twice with PBS, and then 500 µl of trypsin
solution was added. Cells were incubated for 10 min at room
temperature, and then 20 µg of AR expression vector, 400 µg of
DEAE-dextran and 0.1 mM chloroquine were added. The cells
were incubated for 4 h, followed by a DMSO shock for 2 min.
At 1 h before harvesting, testosterone (0.1 µM) was added to
the cells. Cells were washed twice with chilled PBS, collected in the
binding buffer [20 mM Tris}HCl (pH 7.5), 2 mM dithiothreitol,
20% (v}v) glycerol and 0.4 M KCl for AR binding assays, or
20 mM Tris}HCl (pH 7.5), 2 mM dithiothreitol, 20% (v}v)
glycerol and 0.55 M KCl for GR binding assays]. Whole-cell
extracts were prepared by freezing the cells at ®80 °C, thawing
them over ice and centrifuging at 10000 g for 15 min at 0 °C in
a Sigma centrifuge. The supernatant was stored at ®80 °C.
AR- or GR-enriched cells infected with baculovirus were
prepared as described previously [19–21].
Electrophoretic mobility shift assay (EMSA)
GRE oligonucleotides (see Figure 1) were hybridized and $#P-
labelled using the Klenow fragment of DNA polymerase I,
essentially as described by Cao et al. [22]. Binding reactions were
carried out in 20 µl of buffer containing 20 mM Tris}HCl (pH
7.8), 1 mM dithiothreitol, 1 mM EDTA, 10% (v}v) glycerol,
3 µg}µl BSA, 100 mM NaCl, 0.3 ng of radiolabelled purified
DNA probe and 2 µg of dI[dC. AR or GR, in the amounts
indicated in the Figure legends, was then added. After incubation
at room temperature for 15 min, the reaction mixtures were
loaded on a pre-electrophoresed (100 V}12 cm; 30 min) 4.5%
(w}v) acrylamide gel (acrylamide}bisacrylamide, 29:1, w}w)
containing 0.25¬ Tris}borate}EDTA, and electrophoresis was
continued for 90 min (200 V}12 cm). Gels were dried and
autoradiographed. In order to quantify the retarded complexes,
the bands were excised from the gel and radioactivity was
counted in a scintillation counter. Alternatively, the densitometric
studies were performed using NIH Image software.
RESULTS
Lack of activation of the cAspAT gene promoter by testosterone
We compared the effects of androgens and glucocorticoids on the
cAspAT gene promoter. We co-transfected either the GR or AR
expression vector into the HepG2 cells along with p-2405}
®26CAT, a plasmid that contains a 2.4 kb fragment of the
cAspAT gene promoter upstream of the CAT gene. As expected,
0.1 µM dexamethasone activated by 9-fold the ®2405}®26
promoter fragment when co-transfected with 0.05 µg of GR
expression vector [8] (Figure 2). In contrast, 0.1 µM testosterone
did not or only weakly activated this promoter fragment in the
presence of 0.25 µg or 2.5 µg ofARexpression vector respectively.
The use of several deletion fragments of the promoter has
suggested that glucocorticoids regulate the cAspAT gene pro-
moter through two sites [8,23]. Upon deletion of the distal site
(®1983}®1718 [8]), part of the glucocorticoid effect was con-
served. The proximal effect of glucocorticoids is mediated by the
Figure 2 Effects of androgens and glucocorticoids on cAspAT promoter
fragments
HepG2 cells were transfected with plasmids containing deletion fragments of the cAspAT gene
promoter and with either the GR expression vector (0.05 µg) or the AR expression vector
(0.25 µg and 2.5 µg). Testosterone (0.1 µM) or dexamethasone (0.1 µM) was added for 24 h.
The fold activation of the promoters by either testosterone in the presence of AR or
dexamethasone in the presence of GR was calculated. The results are means³S.E.M. of four
independent experiments.
GRE A-containing sequence (compare the ®553}®26 and the
®398}®26 fragments [9]). Interestingly, the ®553}®26 pro-
moter fragment, which includes GRE A, is also not able to
mediate the testosterone response, nor are the other smaller
promoter fragments. These results indicate that this GRE A-
containing cAspAT gene promoter fragment is regulated by
dexamethasone, but not by testosterone, in HepG2 cells.
To determine whether the inability of the AR to activate the
®553}®26 cAspAT promoter fragment was due to the promoter
context or to the intrinsic properties of the GRE A, we subcloned
the GRE A upstream of the heterologous TK promoter. The
effects of androgens and glucocorticoids on the GRE A–TK and
cGRE–TK promoters were compared. As shown in Figure 3(A),
0.1 µM testosterone activated the cGRE–TK promoter as a
function of the amount of transfected AR expression vector, in
agreement with the cGRE being a known target of the AR. In the
case of the GRE A, no increase was observed with 0.5 or 2.5 µg
of AR expression vector in the presence of 0.1 µM testosterone.
These results suggest that the GRE A is not active as an
androgen response element either in the context of the natural
cAspAT promoter or when fused to a heterologous promoter.
Similar experiments performed using a GR expression vector
resulted in activation of both cGRE- and GRE A-containing
promoters, by 7- and 5-fold respectively, in the presence of 0.5 µg
of transfected GR expression vector and 0.1 µM dexamethasone
(Figure 3B).
We next investigated whether the lack of GRE A-mediated
transcriptional activation by the AR could be due to the inability
of the AR to activate promoters containing overlapping GREs.
A sequence consisting of two overlapping cGREs (ov-cGRE,
formerly GRE Aup [9]), which is derived from GRE A, was
created by transforming half-sites 2 and 3 into high-affinity half-
sites (Figure 1). As shown in Figure 3(A), testosterone efficiently
activated the ov-cGRE–TK promoter in the presence of 0.5 and
2.5 µg of transfected AR expression vector, and this activation
was 3–4-fold greater than that of cGRE–TK, suggesting syn-
ergistic activation from two overlapping cGREs. Transcriptional
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Figure 3 Functionality of GRE A
HepG2 cells were transfected with the indicated amounts of the AR (A) or the GR (B) expression
vector, together with cGRE–TK–CAT, GRE A–TK–CAT or ov-cGRE–TK–CAT. After 24 h, cells
were treated with testosterone (0.1 µM) (A) or dexamethasone (0.1 µM) (B). The fold activation
of the promoters by either testosterone in the presence of AR or dexamethasone in the
presence of GR was calculated. The results are means³S.E.M. of four independent
determinations.
activation elicited by the GR on the ov-cGRE–TK–CAT con-
struct was 3 times that with cGRE–TK–CAT (Figure 3B).
Receptor-binding specificity of GRE A
We compared the ability of the AR and the GR to bind to the
GRE A using extracts from cells overexpressing the receptors
(baculovirus-infected Sf9 cells or transfected Cos7 cells). In order
to verify whether the amounts of GR and AR in Sf9 cell extracts
were comparable, Scatchard analysis was carried out using the
cGRE probe and EMSA (results not shown). We determined
the amount of functional receptors in each extract, and we found
that, under the experimental conditions used, the affinity of the
GR for the cGRE oligonucleotide was similar to that of the AR
(K
d
approx. 2 nM; two independent experiments). We next
compared the ability of the AR and the GR to bind to the
GREA, cGREandov-cGREprobes using these extracts (approx.
12 fmol of each receptor in each assay mixture). In the case of
cGRE, a band of similar intensity was observed with both the
GR and the AR, corresponding to dimeric GR–GRE and
AR–GRE complexes respectively (Figure 4, lanes 2 and 5). In the
case of GRE A, a slower-migrating band was observed with
the GR, which corresponded to the tetrameric GR–GRE A
complex reported previously by Garlatti et al. [9] (Figure 4, lane
1). In contrast, no complex was observed with the AR (Figure 4,
lane 4). In additional experiments, we were unable to observe any
complex-formation between GRE A and the AR, even when the
amounts of the AR and of the GRE A probe were increased by
Figure 4 Receptor-binding specificity of GRE A
EMSA experiments were performed by incubating Sf9 extracts containing approx. 12 fmol of
GR (lanes 1–3) or AR (lanes 4–6) with 0.2 ng (50000 c.p.m.) of radiolabelled GRE A (lanes
1 and 4), cGRE (lanes 2 and 5) or ov-cGRE (lanes 3 and 6) probe, and the complexes were
revealed by EMSA. The upper thick arrow indicates the putative tetrameric complex, and the
lower thin arrow indicates the dimeric complex. This experiment was repeated three times with
essentially identical results.
up to 10-fold (results not shown). The inability of the AR to bind
GRE A is likely to account for the lack of regulation of the
cAspAT gene by testosterone. In the case of ov-cGRE, slow-
migrating complexes were observed with both the GR (lane 3)
and the AR (lane 6), and could correspond to tetrameric
receptor–DNA complexes. Similar results were obtained with all
these probes using AR-enriched extracts from Cos7-transfected
cells (see Figure 5). These data indicate that the sequence of
GRE A, rather than the presence of overlapping GREs, prohibits
AR binding, since the AR as well as the GR could form a tetra-
meric complex with consensus overlapping sequences.
DNA sequence requirement for AR DNA binding
The GRE A consists of two overlapping GREs, GRE 1–2 and
GRE 3–4 (Figure 1). Each GRE consists of a conserved half-site
(1 and 4) and a poorly conserved half-site (2 and 3). In the case
of the GR, each GRE is inactive, but the ability of the GR to
bind GRE A stems from co-operative binding of GR dimers
to overlapping elements [9].
In binding assays, the AR present in extracts from baculovirus-
infected cells (Figure 4) or in Cos7-transfected cells (Figure 5)
was not able to bind the GRE A significantly. In contrast, the
receptor present in either one of the two extracts bound the
ov-cGRE sequence and formed an abundant slow-migrating
complex that could correspond to an AR tetramer. Only a small
amount of the dimer complex was formed, even at low receptor
concentrations, suggesting strong co-operative binding. To in-
vestigate further the contribution of each half-site, GRE A2 and
GRE A3 were synthesized, in which the sequences of GRE A
half-sites 2 and 3 respectively were modified and made as close as
possible to the consensus sequence (Figure 1). GRE A2 bound
predominantly an AR dimer at high AR concentration, while
GRE A3 formed predominantly a tetrameric complex (Figure 5).
We conclude that AR dimers can bind co-operatively to over-
lapping response elements provided that the half-sites are of
sufficient high affinity. In the case of the GRE A, the sequences
of half-sites 2 and 3 account for the inability of the AR to bind
and transactivate.
We have tested the functionality of these constructs in transient
transfection experiments. HepG2 cells were transiently trans-
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Figure 5 Effects of mutations in the poorly conserved half-sites of GRE A
on AR binding
EMSAs were performed with increasing amounts of AR-enriched Cos7 extracts (5 µl, 10 µl and
20 µl) and with the GRE A, cGRE, GRE A2, GRE A3 or ov-cGRE probe (see Figure 1 for
sequences). The upper thick arrow indicates the putative tetrameric form of the AR, and the
lower thin arrow indicates the dimeric complex. The experiment was repeated three times with
identical results.
Figure 6 Functionality of the GRE A2 and GRE A3 sequences
HepG2 cells were transiently transfected with increasing amounts of AR expression vector (0.5
and 2 µg) and with one of the following plasmids : GRE A–TK–CAT, GRE A2–TK–CAT, GRE
A3–TK–CAT or ov-cGRE–TK–CAT. After 24 h, cells were treated with testosterone (0.1 µM)
for an additional 24 h. These results are the means of results from two independent experiments
that differed by less than 20%.
fected with increasing amounts of AR expression vector (0.5 and
2 µg) and with one of the following plasmids: GRE A–TK–CAT,
GRE A2–TK–CAT, GRE A3–TK–CAT and ov-cGRE–
TK–CAT. As shown in Figure 6, testosterone (0.1 µM) did not
activate transcription of the CAT gene from the GRE A plasmid,
while it poorly activated (2-fold) transcription from the GRE
A2-containing promoter. The GRE A3 construct was active in
mediating transcription in the presence of 0.5 µg of transfected
AR expression vector. Furthermore, the GRE A3–TK and ov-
cGRE–TK constructs both activated by 5-fold the transcription
of the CAT gene in the presence of 2 µg of transfected AR
expression vector. The results observed in transfection experi-
ments are in accordance with those of the gel-retardation assays.
Similar experiments were performed using the various promoters
and various concentrations of a GR expression vector. In this
case all promoters were responsive to dexamethasone addition;
GRE A–TK was the least sensitive, while both GRE A2–TK
and GRE A3–TK were as efficient as the ov-cGRE–TK promoter
(results not shown).
DISCUSSION
Members of the subfamily of steroid hormone receptors, which
includes the GR, MR, PR and AR, bind to the same consensus
response element, the GRE, and yet tissue- and cell-specific
effects are observed in io. This is probably accounted
for, in part, by differential tissue-specific expression of the
steroid receptors. However, in cell types that co-express multiple
receptors of the subfamily, the molecular mechanisms underlying
these specific steroid responses are of particular interest. Such
specificity could be explained by regulatory units containing not
only GREs, but also other transcription factor binding sites that
display selective interactions. It could also be due to differential
binding of these receptors to divergent GREs, as shown in the
present study.
Androgen response elements present in natural promoters can
be classified into two groups. The first consists of GRE-like
sequences that bind GRs, PRs, MRs and ARs, and includes the
MMTV (murine mammary tumour virus) 5« GRE, the C3-A and
C3-B sites of the C3 subunit of the rat prostatein gene, and the
GRE in the human growth hormone gene promoter [24]. A
second class consists of sequences that discriminate GR and AR
binding and transactivation. The probasin element ARE-2
displays a higher affinity for the AR than for the GR [25] because
the left half-site (5«-GGTTCT-3«) excludes GR binding. Few
other sequences discriminate androgen from glucocorticoid
effects in itro. Binding-site selection from a pool of degenerate
double-stranded oligonucleotides identified GREs with increased
AR or GR specificity. In one study, oligonucleotides formed of
overlapping direct repeats (DR-1) or a complex arrangement
of repeats (two half-sites are overlapping direct repeats and one
half-site is inverted) were shown to bind exclusively the AR, but
not the GR [26]. The mouse sex-limited protein (Slp) gene is
activated exclusively by androgens, but not by glucocorticoids,
in transient expression studies. This discrimination is due to
combinatorial functions of receptor and non-receptor binding
site sequences [27,28]. Recently, Scheller et al. [29] reported that
the differential action of glucocorticoids and androgens on Slp
regulation was also due to intrinsic properties of the AR. In this
case, interaction of the N-terminal subdomain and the ligand-
binding domain contribute to the androgen-specific gene ac-
tivation. In other studies, it was shown that these interactions
could be influenced by nuclear receptor co-activators [30,31]. It
is also possible that the activity of the AR could be modulated by
interference with other transcription factors, such as RelA [32].
Little is known about natural sequences displaying regulation
by glucocorticoids but not by androgens. In the present report
we show that the cAspAT promoter is regulated by dexa-
methasone, but not by testosterone, even in the presence of the
AR. This regulation is mediated by two sites : one in the distal
region of the cAspAT gene promoter and the second in the
proximal region of the promoter. The second site, GRE A, is
composed of two imperfect overlapping GREs [9] which, when
subcloned in a heterologous promoter, mediates a glucocorticoid
response but not an androgen response. This was not due to the
inability of the AR to mediate transcriptional regulation from
overlapping GREs, since the ov-cGRE unit, which comprises
two overlapping high-affinity GREs, elicited synergistic acti-
vation of transcription by both glucocorticoids and androgens.
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The lack of binding of the AR to GRE A may have resulted
from its inability to form a tetramer, due to steric hindrance. In
fact, the AR is a larger protein than the GR (919 and 777 amino
acids respectively). Thus binding of the first AR dimer may
prevent binding of a second AR dimer on the opposite side of the
DNA double helix. This hypothesis is unlikely, however, because
the ov-cGRE unit binds co-operatively either two dimers or a
tetramer of the AR. Even at low AR concentrations, ov-cGRE
forms a single low-mobility complex with AR, suggesting AR co-
operative binding.
A second possibility for the inability of the AR to bind
GRE A is a low binding affinity. GRE A is formed of two
GREs: GRE 1–2 (5«-GGTACA gaa AGACCT-3«) and GRE 3–4
(5«-AGAAAG acc TGTTCT-3«). Zhou et al. [26], using in itro
selection, and Marschke et al. [33] have shown that the half-site
5«-TGTTCT-3« is required for AR binding. This motif is not
conserved in GRE 1–2, which probably accounts for the lack of
detectable AR binding. Changing A to T in position 3 of GRE
1–2 (GRE A2; Figure 1) allows the binding of the AR pre-
dominantly as a dimer. One difference between this modified
sequence and cGRE is the presence of an A in position 1. It
should be noted, however, that the probasin ARE2 also has an
A at this position, and is able to bind the AR efficiently.
The 5«-TGTTCT-3« motif is present in GRE 3–4, but the left
half-site of GRE 3–4 is not conserved (5«-AGAAAG-3«), which
probably excludes AR binding. Modification of a single base (A
to C at position ®3) in this half-site results in AR binding as two
dimers or a tetramer (GRE A3), although the binding was less
co-operative than with the conserved ov-cGRE. It is noteworthy
that half-site 3 in GRE A3 (5«-AGAACG-3«) is similar to one
half-site of the C3-C-responsive element present in the prostatein
C3 subunit gene, which exhibits similar AR and GR binding.
Thus the presence of a C at position ®3 is important for AR
binding. Although both the A2 and A3 modifications improved
the binding of the AR, they resulted in different binding patterns.
In the case of GRE A3, a low-mobility complex migrating as a
tetramer was observed, which was not the case with GRE A2.
While these observations suggest a critical effect of the modi-
fication of half-site 3, other points have to be taken into
consideration. First, the A3 modification yields a sequence that
is closer to the consensus than does the A2 modification.
Secondly, the modification of a strategic position in half-site 3
(®2) resulted in a modification of half-site 2 at position ­1.
Although unlikely, the latter modification could contribute to
the increased affinity of the sequence for the AR and to the
formation of a tetramer. The data are best accounted for by
the following model : in GRE A, the sequence of half-site 3
prevents AR binding. Once this sequence is modified by the A3
mutation, the binding of the AR dimer to GRE 3–4 facilitates the
binding of a second dimer on GRE 1–2, probably through a
co-operative interaction.
In conclusion, we have shown that the imperfect GRE over-
lapping sequences of GRE A, present in the cAspAT gene
promoter, discriminate glucocorticoid and androgen effects.
However, the co-operative binding of the AR to overlapping
GREs required more conserved response elements. This could be
an intrinsic property of the AR. Amero et al. [34] and Laudet et
al. [35,36] have demonstrated that the AR is the most divergent
member of this subgroup of nuclear receptors, which includes the
GR, the PR, the MR and the AR. Within the 75 amino acids that
form the DNA-binding domain, 17 residues differ between the
AR and the GR, whereas 10 of these residues are conserved
between the MR, GR and PR. This divergence between the AR
and the GR could explain their differential binding to sequences
derived from GRE A.
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